| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | 24fdfded-5d47-07a4-e054-00144ff8d46c | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use MONTELUKAST SODIUM CHEWABLE TABLETS safely and effectively. See full prescribing information for MONTELUKAST SODIUM CHEWABLE TABLETS. Montelukast Sodium Chewable Tablets, for oral use Initial U.S. Approval: 1998 | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use MONTELUKAST SODIUM TABLETS and MONTELUKAST SODIUM CHEWABLE TABLETS safely and effectively. See full prescribing information for MONTELUKAST SODIUM TABLETS and MONTELUKAST SODIUM CHEWABLE TABLETS. Montelukast Sodium Tablets, for oral use. Montelukast Sodium Chewable Tablets, for oral use. Initial U.S. Approval: 1998 | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, USP 600 mg/42.9 mg per 5 mL | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Ondansetron Orally Disintegrating Tablets | 5 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | ONDANSETRON | 4 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Kroger ® DayTime Flu + Severe Cold & Cough | 2 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Kroger ® NiteTime Flu + Severe Cold & Cough | 2 | |
| ASPARTAME | ACTIVE INGREDIENT | Z0H242BBR1 | DRUG FACTS: | 2 | |
| ASPARTAME | ACTIVE MOIETY | Z0H242BBR1 | DRUG FACTS: | 2 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Rite Aid ® Daytime Severe Cold & Cough Relief | 2 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Rite Aid ® Nighttime Severe Cold & Cough Relief | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 1 | |
| ASPARTAME | ACTIVE INGREDIENT | Z0H242BBR1 | DRUG FACTS: | 2 | |
| ASPARTAME | ACTIVE MOIETY | Z0H242BBR1 | DRUG FACTS: | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Ondansetron Orally Disintegrating Tablets, USP Rx only | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Ondansetron Orally Disintegrating Tablets, USP Rx only | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | TopCare Daytime Severe Cold and Cough Berry infused with Menthol and Green Tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Topcare Nighttime Severe Cold and Cough Honey lemon infused with Chamomile and White tea flavors | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Amoxicillin and Clavulanate Potassium 600 mg/42.9 mg per 5 mL Powder for Oral Suspension | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Travel Sickness | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | PRESCRIBING INFORMATION ONDANSETRON ORALLY DISINTEGRATING TABLETS, USP Rx only | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Amoxicillin and Clavulanate Potassium 600 mg/42.9 mg per 5 mL Powder for Oral Suspension | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use amoxicillin and clavulanate potassium for oral suspension, USP safely and effectively. See full prescribing information for amoxicillin and clavulanate potassium for oral suspension, USP. Amoxicillin and Clavulanate Potassium for Oral Suspension, USP Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium for oral suspension and other antibacteria | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use olanzapine orally disintegrating tablets safely and effectively. See full prescribing information for olanzapine orally disintegrating tablets. Olanzapine Orally Disintegrating Tablets for Oral use Initial U.S. Approval: 1996 | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | CLARITHROMYCIN TABLETS, USP AND CLARITHROMYCIN FOR ORAL SUSPENSION, USP Rx only | 4 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, USP, 600 mg/42.9 mg per 5 mL Rx only | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Perrigo Tussin DM Drug Facts | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | CVS Pharmacy Daytime Nighttime Severe Cold & Cough Kit | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 1 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | d2b9e29f-7cc8-470b-9546-9614f8eda199 | 1 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | CVS Pharmacy Daytime Severe Cough and Cold Berry infused with Menthol and Green Tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | CVS Pharmacy Nighttime Severe Cough and Cold Honey lemon infused with Chamomile and White tea flavors | 4 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Once-A-Day Mirtazapine Orally Disintegrating Tablets | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Scot-Tussin Senior SF DMEXP | 5 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Scot-Tussin Expectorant SF Cough | 4 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | afbcbf79-e7cd-4615-a999-9941573882b5 | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Sunmark Fiber Smooth texture Sugar free Orange flavor | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use montelukast sodium safely and effectively. See full prescribing information for montelukast sodium. MONTELUKAST SODIUM tablets and chewable tablets for oral use Initial U.S. Approval: 1998 | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 5 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Amoxicillin and Clavulanate Potassium Powder for Oral Suspension and Chewable Tablets | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use Staxyn safely and effectively. See full prescribing information for Staxyn. STAXYN (vardenafil hydrochloride) orally disintegrating tablets Initial U.S. Approval: 2003 | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use CAMBIA safely and effectively. See full prescribing information for CAMBIA. CAMBIA (Diclofenac Potassium for Oral Solution) Initial U.S. Approval: 1988 | 4 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use MAXALT and MAXALT-MLT safely and effectively. See full prescribing information for MAXALT and MAXALT-MLT. MAXALT (rizatriptan benzoate) tablets, for oral use MAXALT-MLT (rizatriptan benzoate) orally disintegrating tablets Initial U.S. Approval: 1998 | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use olanzapine safely and effectively. See full prescribing information for olanzapine orally disintegrating tablets. Olanzapine Orally Disintegrating Tablets, for Oral use Initial U.S. Approval: 1996 | 4 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR ® (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules Initial U.S. Approval: 1998 | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 1987 | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use Welchol safely and effectively. See full prescribing information for Welchol. Welchol (colesevelam hydrochloride) Tablet, Film Coated, for Oral Welchol (colesevelam hydrochloride) For Suspension, for Oral Initial U.S. Approval: 2000 | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | 08d06e6f-a1d8-4bd9-b851-d63858d55f91 | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 2 | |
| Aspartame | ACTIVE MOIETY | Z0H242BBR1 | Allergies | 1 | |
| Aspartame | ACTIVE INGREDIENT | Z0H242BBR1 | Allergies | 1 | |
| Aspartame | ACTIVE MOIETY | Z0H242BBR1 | Food Allergy - Additive | 1 | |
| Aspartame | ACTIVE INGREDIENT | Z0H242BBR1 | Food Allergy - Additive | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use Welchol safely and effectively. See full prescribing information for Welchol. Welchol (colesevelam hydrochloride) Tablet, Film Coated, for Oral Welchol (colesevelam hydrochloride) For Suspension, for Oral Initial U.S. Approval: 2000 | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | c6d3c1ff-d873-4903-befa-c0ba47034c6e | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use lansoprazole delayed-release orally disintegrating tablets safely and effectively. See full prescribing information for lansoprazole delayed-release orally disintegrating tablets. LANSOPRAZOLE delayed-release orally disintegrating tablets for oral use Initial U.S. Approval: 1995 | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Amoxicillin and Clavulanate Potassium | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Drug Facts | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | Ondansetron Orally Disintegrating Tablets, USP | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | a5fa252a-d39e-4099-a230-b665fbb97a80 | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | babf3b8d-f2ce-407d-9407-728c45eb19ee | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for: PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 1995 | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | night time wal-flu severe cold and cough honey lemon flavor infused with chamomile and white tea flavors | 8 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Day time Severe Cold and Cough berry infused with menthol and green tea flavors | 3 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | night time severe cold and cough honey lemon infused with chamomile and white tea flavors | 3 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Day time Cough and Severe Cold berry infused with menthol and green tea flavors | 7 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | cough and severe cold night time honey lemon infused with chamomile and white tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Day time Severe Cold and cough berry infused with menthol and green tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | night time severe cold and cough honey lemon infused with chamomile and white tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Day time Severe Cold and Cough berry infused with menthol and green tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | night time severe cold and cough honey lemon infused with chamomile and white tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Day time Severe Cold and cough berry infused with menthol and green tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | night time severe cold and cough honey lemon with chamomile and white tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | Day time Severe Cold and Cough berry infused with menthol and green tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | night time severe cold and cough honey lemon infused with chamomile and white tea flavors | 2 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | b897c800-24a2-4e76-8668-498c5515c3d0 | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3999 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3925 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE SINGULAIR (MONTELUKAST SODIUM) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3686 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK] | 1001 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | MONTELUKAST SODIUM TABLET, CHEWABLE [BRYANT RANCH PREPACK] | 1001 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | MONTELUKAST SODIUM TABLET, CHEWABLE [BRYANT RANCH PREPACK] | 1001 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | MECLIZINE HCL TABLET [BRYANT RANCH PREPACK] | 1000 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK] | 1000 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK] | 1000 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | MIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK] | 1000 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE [BRYANT RANCH PREPACK] | 1000 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE [BRYANT RANCH PREPACK] | 1000 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 456 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 56 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED ISENTRESS (RALTEGRAVIR) TABLET, CHEWABLE ISENTRESS (RALTEGRAVIR) GRANULE, FOR SUSPENSION [MERCK SHARP & DOHME CORP.] | 49 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | SINGULAIR (MONTELUKAST SODIUM) GRANULE SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE SINGULAIR (MONTELUKAST SODIUM) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.] | 48 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | FAZACLO (CLOZAPINE) TABLET, ORALLY DISINTEGRATING [JAZZ PHARMACEUTICALS, INC.] | 33 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | 33 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | MOVIPREP (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE) KIT [SALIX PHARMACEUTICALS, INC.] | 30 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE PREVACID SOLUTAB (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 28 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | CELLCEPT (MYCOPHENOLATE MOFETIL) TABLET, FILM COATED CELLCEPT (MYCOPHENOLATE MOFETIL) CAPSULE CELLCEPT (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLCEPT (MYCOPHENOLATE MOFETIL) POWDER, FOR SUSPENSION [GENENTECH, INC.] | 26 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE [PD-RX PHARMACEUTICALS, INC.] | 26 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | VIMPAT (LACOSAMIDE) TABLET, FILM COATED VIMPAT (LACOSAMIDE) KIT VIMPAT (LACOSAMIDE) INJECTION VIMPAT (LACOSAMIDE) SOLUTION [UCB, INC.] | 26 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] | 22 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | VIRACEPT (NELFINAVIR MESYLATE) TABLET, FILM COATED VIRACEPT (NELFINAVIR MESYLATE) POWDER [AGOURON] | 22 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.] | 21 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | MONTELUKAST SODIUM TABLET, FILM COATED MONTELUKAST SODIUM TABLET, CHEWABLE [QUALITEST PHARMACEUTICALS] | 20 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | REMERONSOLTAB (MIRTAZAPINE) TABLET, ORALLY DISINTEGRATING [ORGANON USA INC.] | 20 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | MONTELUKAST SODIUM TABLET, COATED MONTELUKAST SODIUM TABLET, CHEWABLE [DR.REDDY'S LABORATORIES LIMITED] | 17 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED AMOXICILLIN AND CLAVULANATE POTASSIUM POWDER, FOR SUSPENSION AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, CHEWABLE [SANDOZ INC] | 16 | |